We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inovio Initiates Phase 1 Trial of COVID-19 Vaccine
Inovio Initiates Phase 1 Trial of COVID-19 Vaccine
Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, clearing the way for a clinical trial.